Bandingkan kaedah
Semak kaedah pilihan anda secara bersebelahan; baris yang berbeza akan diserlahkan.
| Eksperimen Faktorial Pecahan Buta Tunggal× | Ujian Terkawal Rawak Buta Tunggal× | |
|---|---|---|
| Bidang | Reka Bentuk Eksperimen | Reka Bentuk Eksperimen |
| Keluarga | Process / pipeline | Process / pipeline |
| Tahun asal≠ | 1940s–1950s (fractional factorial foundations); blinding conventions formalised through 1960s–1980s | 1948 (formalized); single-blind variant established in mid-20th century clinical trial methodology |
| Pengasas≠ | Fractional factorial theory: R. L. Plackett & J. P. Burman (1946); single-blinding practice codified in clinical trial methodology (20th century) | Bradford Hill and colleagues (MRC streptomycin trial, 1948); blinding conventions codified in CONSORT guidelines |
| Jenis≠ | Controlled experimental design | Experimental design — blinded randomized trial |
| Sumber perintis≠ | Box, G. E. P., Hunter, J. S., & Hunter, W. G. (2005). Statistics for Experimenters: Design, Innovation, and Discovery (2nd ed.). Wiley-Interscience. ISBN: 978-0471718130 | Schulz, K. F., Altman, D. G., Moher, D., & CONSORT Group. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. DOI ↗ |
| Alias | single-masked fractional factorial, single-blind FFD, partially blinded fractional factorial, single-blind 2^(k-p) design | single-masked RCT, single-blind RCT, single-blind trial, SB-RCT |
| Berkaitan | 5 | 5 |
| Ringkasan≠ | A single-blind fractional factorial experiment studies multiple factors simultaneously by testing only a strategically chosen subset — a fraction — of all possible factor-level combinations, while keeping participants unaware of which treatment condition they receive. This design yields substantial information about main effects and selected interactions at a fraction of the cost of a full factorial experiment, with single-blinding reducing participant-side response bias. | A single-blind randomized controlled trial (SB-RCT) is a rigorous experimental design in which participants are randomly assigned to treatment or control conditions while remaining unaware of which condition they have received. Investigators, outcome assessors, and data analysts are not blinded. By masking participants, the design eliminates placebo and nocebo response biases on the participant side, while preserving investigator flexibility to administer and monitor the intervention. |
| ScholarGateSet data ↗ |
|
|